Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D G Jackson

Showing results (1-10 of 70) with videos related to

Pageof 7
Sort By:
Anticancer Research|March 23, 2002
New molecular markers for the study of tumour lymphangiogenesisD G Jackson
Lymphology|April 28, 2004
Hyaluronan and lymphedemaD G Jackson
Biochemical Society Transactions|February 1, 1997
Human leucocyte heparan sulphate proteoglycans and their roles in inflammationD G Jackson
Rehabilitation Record|November 1, 1971
Research utilization in other landsD G Jackson
Lymphology|June 19, 2024
Aselli Award Winner 2023: The Life and Times of a LymphomaniacD G Jackson
The Journal of Biological Chemistry|July 5, 1986
Reaction of neutral endopeptidase 24.11 (enkephalinase) with arginine reagentsD G Jackson, L B Hersh
The Journal of Biological Chemistry|April 25, 1985
Release of the variable surface coat glycoprotein from Trypanosoma brucei requires the cleavage of a phosphate esterD G Jackson, H P Voorheis
Human Immunology|May 1, 1995
TAP2 association with insulin-dependent diabetes mellitus is secondary to HLA-DQB1D G Jackson, J D Capra
Toxicologic Pathology|January 1, 1995
Histopathological and ultrastructural changes in the juxtaglomerular apparatus of the rat following administration of ZENECA ZD6888 (2-ethyl-5,6,7,8-tetrahydro-4-[(2'-(1H-tetrazol-5-yl)biphenyl-4-yl)- methoxy]quinoline), an angiotensin II antagonistD G Jackson, H B Jones
Nurse Practitioner Forum|March 1, 1995
Health promotion strategies for spousal caregivers of chronically ill eldersD G Jackson, B L Cleary
Pageof 7

Showing results (1-10 of 70) with videos related to

Sort By:
Pageof 7
Anticancer Research|March 23, 2002
New molecular markers for the study of tumour lymphangiogenesisD G Jackson
Lymphology|April 28, 2004
Hyaluronan and lymphedemaD G Jackson
Biochemical Society Transactions|February 1, 1997
Human leucocyte heparan sulphate proteoglycans and their roles in inflammationD G Jackson
Rehabilitation Record|November 1, 1971
Research utilization in other landsD G Jackson
Lymphology|June 19, 2024
Aselli Award Winner 2023: The Life and Times of a LymphomaniacD G Jackson
The Journal of Biological Chemistry|July 5, 1986
Reaction of neutral endopeptidase 24.11 (enkephalinase) with arginine reagentsD G Jackson, L B Hersh
The Journal of Biological Chemistry|April 25, 1985
Release of the variable surface coat glycoprotein from Trypanosoma brucei requires the cleavage of a phosphate esterD G Jackson, H P Voorheis
Human Immunology|May 1, 1995
TAP2 association with insulin-dependent diabetes mellitus is secondary to HLA-DQB1D G Jackson, J D Capra
Toxicologic Pathology|January 1, 1995
Histopathological and ultrastructural changes in the juxtaglomerular apparatus of the rat following administration of ZENECA ZD6888 (2-ethyl-5,6,7,8-tetrahydro-4-[(2'-(1H-tetrazol-5-yl)biphenyl-4-yl)- methoxy]quinoline), an angiotensin II antagonistD G Jackson, H B Jones
Nurse Practitioner Forum|March 1, 1995
Health promotion strategies for spousal caregivers of chronically ill eldersD G Jackson, B L Cleary
Pageof 7